Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Gross Margin (2018 - 2025)

Historic Gross Margin for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to 58.43%.

  • Exagen's Gross Margin rose 26100.0% to 58.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 59.86%, marking a year-over-year increase of 10600.0%. This contributed to the annual value of 59.51% for FY2024, which is 34500.0% up from last year.
  • As of Q3 2025, Exagen's Gross Margin stood at 58.43%, which was up 26100.0% from 60.43% recorded in Q2 2025.
  • Over the past 5 years, Exagen's Gross Margin peaked at 62.08% during Q4 2024, and registered a low of 20.09% during Q2 2022.
  • Its 5-year average for Gross Margin is 54.8%, with a median of 58.43% in 2025.
  • Per our database at Business Quant, Exagen's Gross Margin crashed by -372300bps in 2022 and then soared by 386300bps in 2023.
  • Over the past 5 years, Exagen's Gross Margin (Quarter) stood at 61.08% in 2021, then dropped by -17bps to 50.85% in 2022, then rose by 16bps to 59.17% in 2023, then rose by 5bps to 62.08% in 2024, then fell by -6bps to 58.43% in 2025.
  • Its Gross Margin stands at 58.43% for Q3 2025, versus 60.43% for Q2 2025 and 58.87% for Q1 2025.